Efficacy and Safety of Oral Conivaptan, a Vasopressin-Receptor Antagonist, Evaluated in a Randomized, Controlled Trial in Patients With Euvolemic or Hypervolemic Hyponatremia

Oral conivaptan was effective in increasing serum [Na+] in patients with euvolemic or hypervolemic hyponatremia and had a favorable safety profile.